Your browser doesn't support javascript.
loading
[Ossifying fibromyxoid tumor: clinicolpathological futures of 3 cases].
Liu, D; Wang, J; Xiao, Q; Tian, X C; Zhu, C R; Jiang, J X; Wang, C M; Xu, Q; Gu, X W; Hu, H M.
Affiliation
  • Liu D; Department of Pathology, Subei People's Hospital of Jiangsu Province, Yangzhou 225000, China.
  • Wang J; Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • Xiao Q; Department of Pathology, Subei People's Hospital of Jiangsu Province, Yangzhou 225000, China.
  • Tian XC; Department of Pathology, Subei People's Hospital of Jiangsu Province, Yangzhou 225000, China.
  • Zhu CR; Department of Pathology, Subei People's Hospital of Jiangsu Province, Yangzhou 225000, China.
  • Jiang JX; Department of Pathology, Subei People's Hospital of Jiangsu Province, Yangzhou 225000, China.
  • Wang CM; Department of Pathology, Subei People's Hospital of Jiangsu Province, Yangzhou 225000, China.
  • Xu Q; Department of Pathology, Subei People's Hospital of Jiangsu Province, Yangzhou 225000, China.
  • Gu XW; Department of Pathology, Subei People's Hospital of Jiangsu Province, Yangzhou 225000, China.
  • Hu HM; Department of Pathology, Xiangcheng People's Hospital of Jiangsu Province, Suzhou 215131, China.
Zhonghua Bing Li Xue Za Zhi ; 49(2): 174-176, 2020 Feb 08.
Article in Zh | MEDLINE | ID: mdl-32074732

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibroma Limits: Humans Language: Zh Journal: Zhonghua Bing Li Xue Za Zhi Year: 2020 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibroma Limits: Humans Language: Zh Journal: Zhonghua Bing Li Xue Za Zhi Year: 2020 Type: Article Affiliation country: China